These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14720577)

  • 1. VEGF and ALS: the luckiest growth factor?
    Greenberg DA; Jin K
    Trends Mol Med; 2004 Jan; 10(1):1-3. PubMed ID: 14720577
    [No Abstract]   [Full Text] [Related]  

  • 2. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?
    Lambrechts D; Storkebaum E; Carmeliet P
    Trends Mol Med; 2004 Jun; 10(6):275-82. PubMed ID: 15177192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new piece of the ALS puzzle.
    Cleveland JL
    Nat Genet; 2003 Aug; 34(4):357-8. PubMed ID: 12923539
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
    Bogaert E; Van Damme P; Van Den Bosch L; Robberecht W
    Muscle Nerve; 2006 Oct; 34(4):391-405. PubMed ID: 16856151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of the vascular endothelial growth factor in CSF from early ALS patients.
    Devos D; Moreau C; Lassalle P; Perez T; De Seze J; Brunaud-Danel V; Destée A; Tonnel AB; Just N
    Neurology; 2004 Jun; 62(11):2127-9. PubMed ID: 15184633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential.
    Zachary I
    Neurosignals; 2005; 14(5):207-21. PubMed ID: 16301836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.
    Storkebaum E; Lambrechts D; Dewerchin M; Moreno-Murciano MP; Appelmans S; Oh H; Van Damme P; Rutten B; Man WY; De Mol M; Wyns S; Manka D; Vermeulen K; Van Den Bosch L; Mertens N; Schmitz C; Robberecht W; Conway EM; Collen D; Moons L; Carmeliet P
    Nat Neurosci; 2005 Jan; 8(1):85-92. PubMed ID: 15568021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of vascular endothelial growth factor in the regulation of development and functioning of the brain: new target molecules for pharmacotherapy].
    Roslavtceva VV; Salmina AB; Prokopenko SV; Pozhilenkova EA; Kobanenko IV; Rezvitskaya GG
    Biomed Khim; 2016; 62(2):124-33. PubMed ID: 27143368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
    Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
    Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
    Iłzecka J
    Curr Opin Investig Drugs; 2006 Jan; 7(1):54-9. PubMed ID: 16425672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
    Rizvanov AA; Guseva DS; Salafutdinov II; Kudryashova NV; Bashirov FV; Kiyasov AP; Yalvaç ME; Gazizov IM; Kaligin MS; Sahin F; Mukhamedyarov MA; Palotás A; Islamov RR
    Exp Biol Med (Maywood); 2011 Jan; 236(1):91-8. PubMed ID: 21163822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.
    Wang Y; Mao XO; Xie L; Banwait S; Marti HH; Greenberg DA; Jin K
    J Neurosci; 2007 Jan; 27(2):304-7. PubMed ID: 17215390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective function of vascular endothelial growth factor (VEGF).
    Góra-Kupilas K; Jośko J
    Folia Neuropathol; 2005; 43(1):31-9. PubMed ID: 15827888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of AMPA receptors and VEGF in ALS.
    Van Damme P
    Verh K Acad Geneeskd Belg; 2009; 71(4):241-50. PubMed ID: 20084835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype.
    Lambrechts D; Poesen K; Fernández-Santiago R; Al-Chalabi A; Del Bo R; Van Vught PW; Khan S; Marklund SL; Brockington A; van Marion I; Anneser J; Shaw C; Ludolph AC; Leigh NP; Comi GP; Gasser T; Shaw PJ; Morrison KE; Andersen PM; Van den Berg LH; Thijs V; Siddique T; Robberecht W; Carmeliet P
    J Med Genet; 2009 Dec; 46(12):840-6. PubMed ID: 18413368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF: multitasking in ALS.
    Vande Velde C; Cleveland DW
    Nat Neurosci; 2005 Jan; 8(1):5-7. PubMed ID: 15622408
    [No Abstract]   [Full Text] [Related]  

  • 17. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.
    Lambrechts D; Storkebaum E; Morimoto M; Del-Favero J; Desmet F; Marklund SL; Wyns S; Thijs V; Andersson J; van Marion I; Al-Chalabi A; Bornes S; Musson R; Hansen V; Beckman L; Adolfsson R; Pall HS; Prats H; Vermeire S; Rutgeerts P; Katayama S; Awata T; Leigh N; Lang-Lazdunski L; Dewerchin M; Shaw C; Moons L; Vlietinck R; Morrison KE; Robberecht W; Van Broeckhoven C; Collen D; Andersen PM; Carmeliet P
    Nat Genet; 2003 Aug; 34(4):383-94. PubMed ID: 12847526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
    Zheng C; Sköld MK; Li J; Nennesmo I; Fadeel B; Henter JI
    Biochem Biophys Res Commun; 2007 Nov; 363(4):989-93. PubMed ID: 17923114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
    Takahashi H; Shibuya M
    Clin Sci (Lond); 2005 Sep; 109(3):227-41. PubMed ID: 16104843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.